Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters











Publication year range
1.
Exp Ther Med ; 25(1): 57, 2023 Jan.
Article in English | MEDLINE | ID: mdl-36588810

ABSTRACT

Approximately 1.14 billion smokers worldwide are at risk of developing tumors, cardiovascular diseases and respiratory diseases. Smoking cessation is the first choice of health care; however, the disease should be attenuated in individuals who never stop smoking, which escalates medical costs. Therefore, alternative options are needed to manage the social burden. The present study proposed an alternative method to prevent such diseases by inhalation of ß-caryophyllene (BCP). A placebo-targeted, dose-searching, double-blind, parallel-group comparative study was conducted on 19 subjects. The BCP intervention was performed using a flavor capsule inserted in a cigarette filter. The primary endpoint was the reducibility of brachial-ankle pulse wave velocity (baPWV). The secondary endpoints were confirmation of the bioavailability of BCP inhalation with cigarette smoke, confirmation of the effect of BCP inhalation on respiratory function, and association between respiratory function and blood concentration and baPWV reduction. The BCP concentration in the blood reached 4 ng/ml in the BCP 15% group 10 min after inhalation. The baPWV decreased in BCP-inhaling subjects whose initial baPWV was >1,300 cm/sec. The correlation analyses revealed that the higher the forced expiratory volume in 1 sec, the better the transition of baPWV. Inhaled BCP with cigarette smoke could reduce the baPWV and the risk of cardiovascular diseases in smokers. These findings indicated that with the introduction of BCP capsule-cigarettes in the future, smokers will be able to take care of their health, which may help reduce national medical costs. BCP microcapsules placed in cigarette wrapping paper may possibly reduce the risk of sidestream smoke and contribute to improved public health. This clinical research was retrospectively registered in the University Hospital Medical Information Network (UMIN)-Clinical Trials Registry with the following identifications: UMIN000048510 and UMIN000048512 on August 15, 2022.

2.
Biomed Pharmacother ; 153: 113423, 2022 Sep.
Article in English | MEDLINE | ID: mdl-36076543

ABSTRACT

ß-caryophyllene (BCP) is a volatile bicyclic sesquiterpenoid found in essential oils obtained from several spices such as black pepper, oregano, basil, rosemary, cinnamon, and clove. BCP is a selective agonist of cannabinoid receptor 2 (CB2 receptor), and orally administered BCP exhibits various biological activities, including anti-inflammatory, antioxidant, and neuroprotective effects. However, it is still unclear how volatile BCP affects living organisms. We previously reported that inhaled BCP is transferred to sera and organs in mice; additionally, metabolomic analysis revealed inhaled BCP affect the dynamics of metabolites in the livers of mice. These data suggest that inhaled BCP may affect several biological activities by stimulating biological systems. In this study, we evaluated the effects of BCP inhalation on nicotine-induced degeneration of the aortic wall. In the group of mice which inhaled volatile BCP, nicotine-induced increases in elastic fiber degradation and matrix metalloproteinase-2 (MMP-2)-positive areas were attenuated. In addition, BCP improved the nicotine-induced stiffness of aortae and vulnerability to aortic rupture. In cultured aortae, the suppressive effects of BCP were inhibited by the CB2 receptor inhibitor AM630. These results suggest that inhaled BCP is incorporated into the aortic wall and prevents nicotine-induced degeneration of the aorta via a CB2 receptor-dependent pathway.


Subject(s)
Nicotine , Sesquiterpenes , Animals , Aorta , Matrix Metalloproteinase 2 , Mice , Polycyclic Sesquiterpenes , Receptor, Cannabinoid, CB2 , Sesquiterpenes/pharmacology
3.
J Sci Food Agric ; 102(5): 1987-1994, 2022 Mar 30.
Article in English | MEDLINE | ID: mdl-34516661

ABSTRACT

BACKGROUND: Chronic exposure to ultraviolet (UV) radiation promotes skin photoaging, which is clinically characterized by dryness, laxity, and wrinkling. Sea cucumber (Stichopus japonicus) (SC) is a marine organism with culinary and medicinal applications, especially in Asian countries. It is also a potential nutraceutical as it exhibits bioactive effects, such as antioxidant, antitumor, and anticancer activity. This study examined the effects of SC and its hydrolysate (SCH) on ultraviolet A (UVA) induced skin barrier function and wrinkle formation using hairless mice. RESULTS: Ultraviolet A significantly induced transepidermal water loss and wrinkle formation, which were significantly mitigated upon oral administration of SC and SCH. Sea cucumber also mitigated the UVA-induced downregulation of epidermal natural moisturizing factors and the upregulation of Aqp3, Mmp13, Tnfa, and Il6 mRNA levels in the mouse skin. CONCLUSION: Taken together, these results suggest that dietary SC and SCH exert anti-photoaging effects by modulating filaggrin synthesis and desquamation in the epidermis and regulating the NF-κB pathway in the skin. Our research indicates that SC and SCH have potential applications in nutricosmetics for photoaging. © 2021 Society of Chemical Industry.


Subject(s)
Sea Cucumbers , Skin Aging , Animals , Dietary Supplements , Mice , Mice, Hairless , Skin , Ultraviolet Rays/adverse effects
4.
J Oleo Sci ; 69(12): 1597-1607, 2020 Dec 01.
Article in English | MEDLINE | ID: mdl-33177278

ABSTRACT

OBJECTIVES: Plasmalogen, phospholipids with previously shown associations with dementia, has attracted attention as a substance found in some studies to improve cognitive function. The effects of ascidian-derived plasmalogens on cognitive performance improvement were assessed in a randomized, double-blind, placebo-controlled study including Japanese adult volunteers with mild forgetfulness. METHODS: Participants consumed either the active food containing ascidian-derived plasmalogen (1 mg as plasmalogen) or the placebo food for 12 weeks, and their cognitive performance was assessed by Cognitrax. Participants were randomly allocated into the intervention (ascidian-derived plasmalogen; 8 males, and 17 females; 45.6 ± 11.1 years) or the placebo (9 males, and 15 females; mean age, 46.4 ± 10.8 years) group. RESULTS: Compared to the placebo group, the intervention group showed a significant increase score in composite memory (eight weeks: 3.0 ± 16.3 points, 12 weeks: 6.7 ± 17.5 points), which was defined as the sum of verbal and visual memory scores. CONCLUSIONS: These results indicate the consumption of ascidian-derived plasmalogen maintains and enhances memory function. This study was registered at the University Hospital Medical Information Network Clinical Trial Registry (UMIN-CTR, registry no. UMIN000026297). This study did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.


Subject(s)
Cognition/drug effects , Cognitive Dysfunction/drug therapy , Cognitive Dysfunction/psychology , Phytotherapy , Plasmalogens/administration & dosage , Plasmalogens/pharmacology , Urochordata/chemistry , Adult , Animals , Asian People , Double-Blind Method , Female , Humans , Male , Memory/drug effects , Middle Aged
5.
Pharm Res ; 37(3): 64, 2020 Mar 05.
Article in English | MEDLINE | ID: mdl-32140879

ABSTRACT

PURPOSE: The aim of the present study was to develop a new multi-unit dosage formulation, Universal ORbicular Vehicle (UniORV), to improve the biopharmaceutical properties of tacrolimus (TAC). METHODS: TAC-loaded UniORV (UO/TAC) was produced by the dripping and gelling of a solution comprising TAC, gelatin, starch syrup, and triethyl citrate at 0.5 w/w% drug loading. Its microstructure was elucidated by polarized light microscopy and the Raman mapping technique. The pharmacokinetic profiles of TAC after the oral administration of UO/TAC were evaluated in rats and healthy humans. RESULTS: The dissolution behavior of UO/TAC was similar to that of commercial capsules, and the formation of nanoparticles was detected by TEM in dissolved media. In a stability study on UO/TAC, only 2.6 and 4.7% decreases in TAC concentrations were observed at 40± 2°C/75 ± 5% relative humidity for 4 months and at 50± 2°C for 2 months, respectively. A pharmacokinetic study on rats revealed a 30-fold higher AUC than that with crystalline TAC. A randomized double-blind crossover study on 8 healthy males showed that UniORV achieved a 1.4-fold increase in AUC and 34% decrease in inter-individual variation from the reference formulation. CONCLUSION: The new dosage form UniORV is a promising approach to improve the dissolution, amorphous stability, and biopharmaceutical properties of TAC, which is a poorly water-soluble drug.


Subject(s)
Immunosuppressive Agents/administration & dosage , Immunosuppressive Agents/pharmacokinetics , Pharmaceutical Vehicles/chemistry , Tacrolimus/administration & dosage , Tacrolimus/pharmacokinetics , Administration, Oral , Adult , Animals , Citrates/chemistry , Cross-Over Studies , Double-Blind Method , Drug Compounding , Drug Liberation , Gelatin/chemistry , Humans , Immunosuppressive Agents/blood , Male , Rats , Rats, Sprague-Dawley , Starch/chemistry , Tacrolimus/blood , Young Adult
6.
Int J Pharm ; 570: 118630, 2019 Oct 30.
Article in English | MEDLINE | ID: mdl-31425819

ABSTRACT

This study aimed to improve pharmacokinetic behavior and reduce safety concern of cyclosporine A (CsA) by UniORV® approach, a new platform for solid dispersion formulation. CsA-loaded UniORV® (UO/CsA) was prepared, and its physicochemical properties were evaluated in terms of droplet size distribution and dissolution. The pharmacokinetic behavior and nephrotoxic potential of orally-dosed CsA samples (10 mg-CsA/kg) were assessed in rats. After re-dispersion of UO/CsA in water, fine droplets were observed, and the mean diameter of droplets was calculated to be 45 nm. The UniORV® approach markedly improved the dissolution behavior compared with amorphous CsA in water. After oral administration of amorphous CsA, Neoral®, and UO/CsA in rats, UO/CsA exhibited a 32% lower maximum concentration and 5.1 h longer mean residence time than those of Neoral®. The oral absorption of CsA formulations was higher compared with amorphous CsA; in particular, the oral bioavailability of UO/CsA was 71-fold higher than that of amorphous CsA. Neoral® elicited nephrotoxicity with plasma creatinine level of 1.29 mg/dL; however, Neoral®-induced nephrotoxicity was attenuated in UO/CsA, as evidenced by a 15% lower plasma creatinine level of UO/CsA than that of Neoral®. From these findings, UO/CsA might be a promising dosage form with improved biopharmaceutical properties of CsA.


Subject(s)
Cyclosporine/pharmacokinetics , Administration, Oral , Animals , Biological Availability , Chemistry, Pharmaceutical/methods , Cyclosporine/chemistry , Drug Delivery Systems/methods , Male , Rats , Rats, Sprague-Dawley , Solubility/drug effects
7.
In Vivo ; 31(4): 591-598, 2017.
Article in English | MEDLINE | ID: mdl-28652425

ABSTRACT

BACKGROUND: Most previous mastic investigators have not considered its potent cytotoxicity that may significantly affect the interpretation of obtained data. In the present study, we re-evaluated several biological activities of mastic extracts, based on chemotherapeutic indexes. MATERIALS AND METHODS: Pulverized mastic gum was extracted with n-hexane and then with ethyl acetate or independently with methanol or n-butanol. Tumor specificity (TS) of the extracts was determined by their cytotoxicity against human malignant and non-malignant cells. Antibacterial activity was determined by their cytotoxicity against bacteria and normal oral cells. Antiviral activity was determined by their protection of viral infection and cytotoxic activity. Cytochrome P-450 (CYP) 3A4 activity was measured by ß-hydroxylation of testosterone. RESULTS: Ethyl acetate extract showed slightly higher tumor specificity (TS=2.6) and one order higher antibacterial activity (selectivity index (SI)=0.813) than other extracts (TS=1.4-2.5; SI=0.030-0.063). All extracts showed no anti-human immunodeficiency virus (HIV) activity, but some anti-herpes simplex virus (HSV) activity, which was masked by potent cytotoxicity. They showed strong inhibitory activity against CYP3A4. CONCLUSION: Ethyl acetate extraction following the removal of cytotoxic and CYP3A4 inhibitory substances by n-hexane can enhance antitumor and antibacterial activity of mastic.


Subject(s)
Bacteria/drug effects , Mastic Resin/pharmacology , Neoplasms/drug therapy , Plant Extracts/pharmacology , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Antiviral Agents/chemistry , Antiviral Agents/pharmacology , Bacteria/pathogenicity , Cell Proliferation/drug effects , Cytochrome P-450 CYP3A/genetics , HIV/drug effects , HIV/pathogenicity , Hexanes/chemistry , Humans , Mastic Resin/chemistry , Neoplasms/pathology , Pistacia/chemistry , Plant Extracts/chemistry , Simplexvirus/drug effects , Simplexvirus/pathogenicity
8.
J Vet Med Sci ; 75(4): 497-502, 2013 May 02.
Article in English | MEDLINE | ID: mdl-22971527

ABSTRACT

We investigated the correlation of plasma amino acid concentrations and the effects of glucosamine and fish collagen peptide (FCP) on osteoarthritis (OA). OA was induced according to the rabbit anterior cruciate ligament transection (ACLT) model. After surgery, the rabbits were orally administered FCP (F group), glucosamine (G group) or both (FG group) for 4 weeks. The control group (C group) was not administered anything. Blood was collected before surgery (pre-ACLT) and before euthanasia (post-ACLT). Changes in the alanine, threonine and methionine concentrations were significant between pre- and post-ACLT. The correlation between the histological assessment and arginine concentration post-ACLT was significant. These findings indicate that measurement of plasma amino acids is useful for evaluation of the efficacy of intervention for OA.


Subject(s)
Cartilage, Articular/pathology , Collagen/pharmacology , Glucosamine/pharmacology , Osteoarthritis/blood , Osteoarthritis/prevention & control , Rabbits/surgery , Alanine/blood , Animals , Cartilage, Articular/drug effects , Disease Models, Animal , Female , Histocytochemistry , Leucine/blood , Methionine/blood , Osteoarthritis/metabolism , Osteoarthritis/pathology , Statistics, Nonparametric
9.
J Vet Med Sci ; 75(4): 421-9, 2013 May 02.
Article in English | MEDLINE | ID: mdl-23154419

ABSTRACT

The aim of this study was to investigate the correlations of severity of osteoarthritis (OA) and serum biomarkers including keratan sulfate (KS), hyaluronic acid (HA) and chondroitin sulfate (CS) 846 epitope. We also investigated the effect of glucosamine and fish collagen peptide (FCP) on OA. OA was induced in 12 rabbits (12 weeks of age) by anterior cruciate ligament transection (ACLT). After the surgery, the rabbits were orally administered FCP (F group), glucosamine (G group) or FCP and glucosamine (FG group) for 4 weeks. The control group was provided water ad libitum (C group). Blood was collected before surgery (pre-ACLT) and before euthanasia (post-ACLT) for serum marker measurement. Biomarker levels were measured by using commercial kits. We evaluated OA severity both macroscopically and histologically. Macroscopic evaluation showed mildly eroded condylar surfaces in the C group. Histological findings were significantly different from the FG and other groups. There were no significant differences between each group at post-ACLT in terms of serum KS, HA and CS 846. Histological assessment and serum biomarker measurements performed at post-ACLT showed a significant correlation between HA concentration and OA severity. Variations in the CS 846 concentration at pre-ACLT and post-ACLT were significantly correlated with OA severity. Administration of glucosamine and FCP had chondroprotective effects in the ACLT model. Serum biomarker concentrations were significantly correlated with cartilage injury. Serum biomarker measurement would be useful for monitoring articular cartilage damage in the clinical setting.


Subject(s)
Anterior Cruciate Ligament/pathology , Anterior Cruciate Ligament/surgery , Cartilage, Articular/pathology , Collagen/pharmacology , Glucosamine/pharmacology , Osteoarthritis/drug therapy , Animals , Biomarkers/blood , Chondroitin Sulfates/blood , Disease Models, Animal , Histocytochemistry/veterinary , Hyaluronic Acid/blood , Keratan Sulfate/blood , Osteoarthritis/blood , Osteoarthritis/pathology , Osteoarthritis/surgery , Rabbits , Statistics, Nonparametric
10.
Nutr Neurosci ; 13(4): 183-8, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20670474

ABSTRACT

Anserine and L-carnosine are similar dipeptides synthesized by muscles of vertebrates. The functional role of anserine is unknown, although previous studies showed hypoglycemic effects of carnosine through autonomic nerves. Thus, we evaluated the effects of anserine on blood glucose levels and the neural activities. Intraperitoneal administration of specific doses of anserine to hyperglycemic rats reduced hyperglycemia and plasma glucagon concentrations, whereas thioperamide eliminated the effects of anserine. Intraduodenal injection of 0.1 mg anserine to anesthetized rats after laparotomy suppressed sympathetic nerve activity and enhanced activity of the vagal gastric efferent. In addition, oral administration of anserine reduced blood glucose levels during oral glucose tolerance testing in humans. These results suggest the possibility that anserine might be a control factor for the blood glucose, and that histaminergic nerves may be involved in the hypoglycemic effects of anserine.


Subject(s)
Anserine/administration & dosage , Autonomic Pathways/drug effects , Hyperglycemia/drug therapy , Animals , Autonomic Pathways/physiology , Blood Glucose/analysis , Blood Glucose/physiology , Cross-Over Studies , Deoxyglucose/administration & dosage , Efferent Pathways/drug effects , Glucagon/blood , Glucose Tolerance Test , Humans , Hyperglycemia/chemically induced , Hyperglycemia/physiopathology , Hypoglycemic Agents/administration & dosage , Kinetics , Male , Rats , Rats, Wistar , Sympathetic Nervous System/drug effects , Vagus Nerve/drug effects , Vagus Nerve/physiology
11.
Nutr Neurosci ; 13(3): 123-8, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20423561

ABSTRACT

Anserine and L-carnosine are similar dipeptides synthesized by muscles of vertebrates. The functional role of anserine is unknown, although previous studies showed hypoglycemic effects of carnosine through autonomic nerves. Thus, we evaluated the effects of anserine on blood glucose levels and neural activities. Intraperitoneal administration of specific doses of anserine to hyperglycemic rats reduced hyperglycemia and plasma glucagon concentrations, whereas thioperamide eliminated the effects of anserine. Intraduodenal injection of 0.1 mg anserine to anesthetized rats after laparotomy suppressed sympathetic nerve activity and enhanced activity of the vagal gastric efferent. In addition, oral administration of anserine reduced blood glucose levels during oral glucose tolerance testing in humans. These results suggest the possibility that anserine might be a control factor for blood glucose, and that histaminergic nerves may be involved in the hypoglycemic effects of anserine.


Subject(s)
Anserine/therapeutic use , Autonomic Nervous System/drug effects , Hyperglycemia/drug therapy , Hypoglycemic Agents/therapeutic use , Neurons/drug effects , Animals , Anserine/antagonists & inhibitors , Anserine/isolation & purification , Anserine/pharmacology , Blood Glucose/analysis , Cross-Over Studies , Deoxyglucose/administration & dosage , Deoxyglucose/toxicity , Dose-Response Relationship, Drug , Drug Administration Routes , Glucagon/blood , Glucose Tolerance Test , Histamine H3 Antagonists/pharmacology , Humans , Hyperglycemia/blood , Hyperglycemia/chemically induced , Hypoglycemic Agents/antagonists & inhibitors , Hypoglycemic Agents/isolation & purification , Hypoglycemic Agents/pharmacology , Insulin/blood , Male , Rats , Rats, Wistar , Sympatholytics/pharmacology , Time Factors , Vagus Nerve/drug effects
12.
Biochem Biophys Res Commun ; 391(4): 1775-9, 2010 Jan 22.
Article in English | MEDLINE | ID: mdl-20045674

ABSTRACT

Autophagy is a cellular process that nonspecifically degrades cytosolic components and is involved in many cellular responses. We found that amino sugars with a free amino group such as glucosamine, galactosamine and mannosamine induced autophagy via an mTOR-independent pathway. Glucosamine-induced autophagy at concentrations of at least 500 microM to over 40 mM. In the presence of 40 mM glucosamine, autophagy induction was initiated at 6h and reached a plateau at 36 h. Glucosamine-induced autophagy could remove accumulated ubiquitin-conjugated proteins as well as 79-glutamine repeats. Therefore, orally administered glucosamine could contribute to the prevention of neurodegenerative diseases and promotion of antiaging effects.


Subject(s)
Autophagy , Glucosamine/pharmacology , Intracellular Signaling Peptides and Proteins/metabolism , Protein Serine-Threonine Kinases/metabolism , Animals , COS Cells , Chlorocebus aethiops , Cytosol/metabolism , Humans , Intracellular Signaling Peptides and Proteins/antagonists & inhibitors , Protein Kinase Inhibitors/pharmacology , Protein Serine-Threonine Kinases/antagonists & inhibitors , TOR Serine-Threonine Kinases
13.
J Agric Food Chem ; 57(5): 1781-5, 2009 Mar 11.
Article in English | MEDLINE | ID: mdl-19256552

ABSTRACT

Anserine is a bioactive dipeptide found in muscles and brains of vertebrates, but little is known about the kinetics of its absorption into blood and the clearance after the ingestion of anserine or anserine-containing diets. This study investigated time-dependent changes in the concentrations of l-histidine-related compounds from deproteinized blood. The concentration of anserine peaked and then decreased to zero, whereas the concentration of pi-methylhistidine gradually increased, at which point anserine was not detected. Thus, ingested anserine is absorbed intact in human blood and is hydrolyzed to pi-methylhistidine and beta-alanine by serum and tissue carnosinases. Moreover, the crossover study suggests that there was no significant difference in absorption under curves of anserine between anserine alone and anserine-containing diet, whereas there was significant difference in the peak concentration of anserine. This is the first study to demonstrate intestinal absorption and blood clearance of anserine.


Subject(s)
Anserine/pharmacokinetics , Eating , Histidine/blood , Intestinal Absorption , Adult , Anserine/administration & dosage , Anserine/blood , Diet , Female , Histidine/analogs & derivatives , Humans , Male
14.
J Med Chem ; 51(15): 4496-503, 2008 Aug 14.
Article in English | MEDLINE | ID: mdl-18651726

ABSTRACT

We verified here the inhibitory activity of a sialylglycopolymer prepared from natural products, chitosan and hen egg yolk, against influenza virus infection and estimated the requirements of the molecule for efficient inhibition. The inhibitory activity clearly depended on two factors, the length (the degree of polymerization: DP) of the chitosan backbone and the amount (the degree of substitution: DS) of conjugated sialyloligosaccharide side chain. The inhibitory efficiency increased in accordance with the DP value, with the highest inhibitory activity obtained when the DP was 1430. The inhibition of virus infection reached more than 90% as the DS value increased up to 15.6% when the neighboring sialyloligosaccharide side chains came as close as 4 nm, which was nearly the distance between two receptor-binding pockets in a hemagglutinin trimer. These results demonstrate that the sialylglycopolymer could be an excellent candidate of the safe and efficient anti-influenza drug.


Subject(s)
Chitosan/chemical synthesis , Chitosan/pharmacology , Drug Design , Glucose/chemistry , N-Acetylneuraminic Acid/chemistry , Orthomyxoviridae Infections/prevention & control , Cell Line , Chitosan/chemistry , Humans , Influenza A Virus, H1N1 Subtype/drug effects , Influenza A Virus, H3N2 Subtype/drug effects , Influenza B virus/drug effects , Models, Molecular , Molecular Structure
15.
Biol Pharm Bull ; 30(3): 583-4, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17329861

ABSTRACT

Candida albicans generally grows in the hyphae form in RPMI1640 medium. Chitohexose (COS-6) induced the yeast form of C. albicans dose-dependently under this condition. When COS-6 was exposed to C. albicans, yeast proliferation was observed 6 h after starting the incubation. When we observed the growth form of C. albicans cultured with COS-6, yeast proliferation was observed at log-phase. These results showed that COS-6 was useful for the yeast form inducer of C. albicans.


Subject(s)
Candida albicans/drug effects , Oligosaccharides/pharmacology , Candida albicans/cytology , Candida albicans/growth & development , Cell Division/drug effects , Colony Count, Microbial/methods , Dose-Response Relationship, Drug , Time Factors
17.
Biol Pharm Bull ; 28(10): 1971-3, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16204957

ABSTRACT

The purpose of the present study was to examine whether chitobiose and chitotriose can protect rats from CCl4-induced hepatic toxicity when given orally. We studied the effects of the 2 chitooligosaccharides given orally to rats on the acute hepatotoxicity induced by CCl4-dependent lipid peroxidation. The increase in the sum of malondialdehyde and 4-hydroxy-2-alkenals, a marker of lipid peroxidation, in both plasma and liver of CCl4-treated rats was suppressed by oral administration of chitobiose or chitotriose. The elevation in the levels of plasma aspartate transaminase and alanine transaminase activities, markers of hepatic injury, induced by CCl4 intoxication was also counteracted by oral administration of either chitooligosaccharide. The results indicate that chitobiose and chitotriose have the ability to exert a protective action against CCl4-induced acute hepatoxicity, probably by their antioxidant activity.


Subject(s)
Carbon Tetrachloride Poisoning/prevention & control , Disaccharides/pharmacology , Liver/drug effects , Trisaccharides/pharmacology , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/blood , Carbon Tetrachloride Poisoning/blood , Carbon Tetrachloride Poisoning/enzymology , Male , Rats , Rats, Wistar
18.
Biol Pharm Bull ; 28(3): 545-8, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15744088

ABSTRACT

Chitooligosaccharides have attracted much attention as new biomedical materials. The biologic availability of each of these chitooligosaccharides, however, has not yet been studied. In the present study, we found that chitobiose and chitotriose appeared in the blood of rats with maximum plasma concentrations at around 1 h after administration when given orally at a dose of 30 mg/kg. However, chitotetraose and chitopentaose did not appear in the blood when given at a dose of 300 mg/kg. Pharmacokinetic analysis of chitobiose and chitotriose after intravenous administration at 100 mg/kg revealed that both sugars were eliminated from the body following a one-compartment model and that the former relative to the latter was higher for both the total body clearance (224+/-43 vs. 155+/-26 ml/h/kg) and the distribution volume (107+/-15 vs. 65+/-9 ml/kg). The absolute oral bioavailability of chitobiose was higher than that of chitotriose at all doses (30, 100, and 300 mg/kg) examined. The first-order absorption rate constants for chitobiose and chitotriose at all doses were less than 1.0 h(-1) and smaller than the elimination rate constants (2.2+/-0.3, 2.7+/-0.1 h(-1), respectively). The absorption was slow, resulting in flip-flop kinetics. This study indicates that among various chitooligosaccharides, only chitobiose and chitotriose can be appreciably absorbed from the gastrointestinal tract.


Subject(s)
Disaccharides/administration & dosage , Disaccharides/pharmacokinetics , Trisaccharides/administration & dosage , Trisaccharides/pharmacokinetics , Administration, Oral , Animals , Dose-Response Relationship, Drug , Injections, Intravenous , Male , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL